Gut-Derived Immune Activation in Rheumatoid Arthritis: A Conceptual Parallel to <em>Ama </em>in <em>Amavata</em>

Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease in which clinically apparent synovitis is preceded by a prolonged preclinical phase characterized by immune dysregulation and autoantibody formation. Growing evidence implicates gut dysbiosis, impaired intestinal barrier integrity, and gut-derived immune priming as upstream contributors to RA pathogenesis, occurring years before overt joint inflammation. In parallel, Ayurveda describes Amavata as a chronic systemic disorder arising from the formation of Ama, a pathogenic burden produced by impaired digestive and metabolic function (Agni), which accumulates silently, disseminates systemically, and later localizes to the joints. Methods: This conceptual review draws on peer-reviewed biomedical and Ayurvedic literature to examine potential functional correspondences between the Ayurvedic construct of Ama in Amavata and contemporary models of gut-derived immune activation in RA, with emphasis on shared temporal and systemic features of disease development. Results: Both frameworks locate disease initiation upstream of overt inflammation and describe a prolonged preclinical phase characterized by systemic pathogenic processes. Ama is interpreted not as inflammation or tissue injury, but as a preclinical, systemic pathogenic state functionally analogous to chronic gut dysbiosis, barrier dysfunction, and immune priming described in RA. The analysis identifies a structural contrast in explanatory logic: Ayurveda integrates multiple upstream processes into a single unifying construct, whereas biomedicine analytically separates them into discrete mechanisms. The proposed mapping is heuristic and non-reductive, without asserting one-to-one equivalence or molecular translation. Conclusions: By situating both Amavata and RA within a shared preclinical, systemic disease framework, this model reinforces the importance of early, preventive intervention targeting metabolic and gut-immune dysregulation prior to irreversible joint damage. The findings demonstrate convergent reasoning across distinct medical traditions and support integrative, systems-oriented perspectives on chronic inflammatory disease initiation.